Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/248932 
Year of Publication: 
2021
Series/Report no.: 
CESifo Working Paper No. 9387
Publisher: 
Center for Economic Studies and ifo Institute (CESifo), Munich
Abstract: 
This paper discusses the relationship between medical innovations and ageing from a health economics perspective and surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health innovations. Particular focus is on the endogeneity of medical technological progress to expected market size and on the conceptualization of ageing as an accumulation of health deficits. The paper also discusses the role of medical progress for longevity and health inequality and presents a framework to assess the effect of increased longevity on the value of life.
Subjects: 
healthcare
health deficits
health innovations
medical technological progress
longevity
JEL: 
I10
O30
Document Type: 
Working Paper
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.